Feasibility and 1-year outcome of transcatheter closure of perimembranous ventricular septal defects with different devices

被引:16
作者
Shrestha, Manish [1 ]
Promphan, Worakan [1 ]
Layangool, Thanarat [1 ]
Roymanee, Supaporn [2 ]
Wongwaitaweewong, Kanjarut [2 ]
Prachasilchai, Pimpak [1 ]
Kirawittaya, Tawatchai [1 ]
Sangtawesin, Chaisit [1 ]
Pattarakunwiwat, Panthip [1 ]
机构
[1] Rangsit Univ, Queen Sirikit Natl Inst Child Hlth, Coll Med, Pediat Cardiac Ctr, Bangkok, Thailand
[2] Prince Songkla Univ, Dept Pediat, Fac Med, Hat Yai, Thailand
关键词
complete heart block; device; perimembranous ventricular septal defect; transcatheter closure; FOLLOW-UP; PERCUTANEOUS CLOSURE; SURGICAL CLOSURE; OCCLUDER; CHILDREN;
D O I
10.1002/ccd.27851
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To analyze feasibility of closing perimembranous ventricular septal defect (pmVSD) with different devices by percutaneous approach and determining initial 1-year outcome of the procedure. Background Transcatheter closure of pmVSD remains controversial due to a previous higher incidence of complete heart block (CHB), especially with the Amplatzer pmVSD occluder. Recently, several devices have been used to minimize the procedure-related complications. Methods and materials A retrospective longitudinal cohort study of 133 patients who underwent transcatheter closure of pmVSD from September 2009 to March 2015. The median age and weight at intervention were 7.1 years (ranging from 9 months to 28 years) and 21.2 kg (ranging from 6.4 to 93 kg). Results Transcatheter pmVSD closure was successfully performed in 129 cases (97%) using 13 different devices. There were two new onset severe aortic regurgitation (AR) (1.5%), one new onset severe tricuspid regurgitation (0.7%), and one CHB (0.7%). Immediately after procedure, 41 patients (30.8%) had mild to moderate residual shunt and 27 patients (20.8%) had trivial to mild AR. At 1 year, there was no CHB and 10 patients (9.6%) had tiny to mild residual shunt and 10 patients (9.6%) had trivial AR. Conclusion With proper case selection, good expertise, and judicious use of various devices with respect to anatomic details of pmVSD, transcatheter closure is feasible with satisfactory early outcome.
引用
收藏
页码:E30 / E37
页数:8
相关论文
共 18 条
[1]   Initial human experience with the Amplatzer perimembranous ventricular septal occluder device [J].
Bass, JL ;
Kalra, GS ;
Arora, R ;
Masura, J ;
Gavora, P ;
Thanopoulos, BD ;
Torres, W ;
Sievert, H ;
Carminati, M ;
Fischer, G ;
Ewert, P .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 58 (02) :238-245
[2]   Percutaneous closure of ventricular septal defects in children aged <12:: early and mid-term results [J].
Butera, Gianfranco ;
Carminati, Mario ;
Chessa, Massimo ;
Piazza, Luciane ;
Abella, Raul ;
Negura, Diana Gabriella ;
Giamberti, Alessandro ;
Claudio, Bussadori ;
Micheletti, Angelo ;
Tammam, Youssef ;
Frigiola, Alessandro .
EUROPEAN HEART JOURNAL, 2006, 27 (23) :2889-2895
[3]   Transcatheter closure of congenital ventricular septal defects: results of the European Registry [J].
Carminati, Mario ;
Butera, Gianfranco ;
Chessa, Massimo ;
De Giovanni, Joseph ;
Fisher, Gunter ;
Gewillig, Marc ;
Peuster, Mathias ;
Piechaud, Jean Francois ;
Santoro, Giuseppe ;
Sievert, Horst ;
Spadoni, Isabella ;
Walsh, Kevin .
EUROPEAN HEART JOURNAL, 2007, 28 (19) :2361-2368
[4]   The results of transcatheter closure of VSD using amplatzer® device and nit occlud® Le coil [J].
Chungsomprasong, Paweena ;
Durongpisitkul, Kritvikrom ;
Vijarnsorn, Chodchanok ;
Soongswang, Jarupim ;
Trong Phi Le .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2011, 78 (07) :1032-1040
[5]   Closure of Perimembranous Ventricular Septal Defects with Aneurysmal Tissue Using the Amplazter Duct Occluder I: Lessons Learned and Medium Term Follow Up [J].
El Said, Howaida G. ;
Bratincsak, Andras ;
Gordon, Brent M. ;
Moore, John W. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (06) :895-903
[6]   Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease A Scientific Statement From the American Heart Association [J].
Feltes, Timothy F. ;
Bacha, Emile ;
Beekman, Robert H., III ;
Cheatham, John P. ;
Feinstein, Jeffrey A. ;
Gomes, Antoinette S. ;
Hijazi, Ziyad M. ;
Ing, Frank F. ;
de Moor, Michael ;
Morrow, W. Robert ;
Mullins, Charles E. ;
Taubert, Kathryn A. ;
Zahn, Evan M. .
CIRCULATION, 2011, 123 (22) :2607-2652
[7]   Transcatheter closure of perimembranous ventricular septal defects using the new amplatzer membranous VSD occluder - Results of the US phase I trial [J].
Fu, YC ;
Bass, J ;
Amin, Z ;
Radtke, W ;
Cheatham, JP ;
Hellenbrand, WE ;
Balzer, D ;
Cao, QL ;
Hijazi, ZM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (02) :319-325
[8]   Follow-Up of Patients with Interventional Closure of Ventricular Septal Defects with Amplatzer Duct Occluder II [J].
Kanaan, M. ;
Ewert, P. ;
Berger, F. ;
Assa, S. ;
Schubert, S. .
PEDIATRIC CARDIOLOGY, 2015, 36 (02) :379-385
[9]  
Lewin MB, 2013, MOSS ADAMS HEART DIS, V8th, P713
[10]   Percutaneous closure of perimembranous ventricular septal defects with the eccentric amplatzer device: Multicenter follow-up study [J].
Masura, J ;
Gao, W ;
Gavora, P ;
Sun, K ;
Zhou, AQ ;
Jiang, S ;
Ting-Liang, L ;
Wang, Y .
PEDIATRIC CARDIOLOGY, 2005, 26 (03) :216-219